RSS

rosacea

International contract development and manufacturing organisation (CDMO), Hovione has announced the enrolment of the first patient in the Phase II clinical trial of its topical minocycline (HY01) in moderate to severe papulopustular rosacea patients. more

News

New Zealand kanuka honey formulation Honevo gives renewed hope to the 5–10% of adults who suffer from rosacea after a large clinical trial proved it an effective and safe treatment of the condition. more

News